StatusGoStrategy in Motion AI in Healthcare · A Weekly Point of View
 
In This Issue
→Affordability decided the midterms, and the market repriced coverage within a day
→CVS is splitting in two, and unwinding the integration it spent a decade assembling
→AI is answering members, reading contracts and abstracting charts faster than anyone is measuring it
By the Numbers: The New Balance of Power 2026 midterms, as of Nov 10
US Senate
54
DEM +7
44
REP -9
   
Flip to Dem. · 2 uncalled
US House
254
DEM +39
162
REP -58
   
Flip to Dem. · 19 uncalled
Governors
28
DEM +5
20
REP -7
   
Dem +5 so far · 2 uncalled

Affordability and the war decided this election, and healthcare came along with it. Cost of living was named a major factor by 89% of voters in the NBC exit poll, and KFF found voters trusting Democrats on healthcare by 49 to 30. A wave of clinician candidates won on that message, and five themes carried the winning campaigns.

Change shown versus seats held before the election. Counts from the Associated Press, governors via Ballotpedia. Two Senate races are still uncalled a week on: Scott Colom leads Cindy Hyde-Smith by roughly 2,500 votes in Mississippi, where counties certify Friday and state law provides no recount, and Mary Peltola leads Dan Sullivan by a similar margin in Alaska, where ranked choice tabulation has yet to run. Either one would put Democrats at 55.

Five themes the winners ran on

1. Restore and expand ACA subsidies. The central affordability message, led party-wide by Democratic leader Hakeem Jeffries (the expected Speaker) and Sen. Ron Wyden as the enhanced marketplace subsidies expired.

2. Protect and restore Medicaid. Reverse the roughly $1 trillion in HR 1 cuts and oppose work requirements. Keisha Lance Bottoms (GA governor) ran on full expansion, Amy Acton (OH) on protecting it, and Gina Hinojosa, who ousted Greg Abbott in Texas, opens expansion in the largest holdout state.

3. Lower prescription drug costs. A universal pillar, now with oversight teeth. Xavier Becerra (CA governor) and Acton campaigned on it; Wyden will chair Senate Finance and the new House majority gains subpoena power.

4. Medicare for All, or expand Medicare. A minority position rather than a party-wide platform, championed by physician Abdul El-Sayed, who won Michigan’s Senate seat.

5. Defend vaccines and public health. Pediatrician Annie Andrews won South Carolina’s Senate seat on vaccine access and care as a right, part of a wave of clinician candidates.

The market bet on more covered lives

One-day moves, Nov 4 · Becker’s

Payers
Centene +12.6% · Molina +8.9% · Elevance +4.9% · Cigna +3.4% · UnitedHealth +1.2%
Hospitals
Community Health Systems +16.1% · UHS +10.9% · HCA +10.3% · Tenet +9.6%
Pharma
J&J +3.8% · AbbVie +3.1% · Pfizer +2.6% · Eli Lilly +0.6%

Every name that moved is one whose revenue tracks how many people are covered, so Wednesday was a bet that subsidies get restored and the HR 1 Medicaid cuts get delayed. Pharma sat still, which says nobody expects real movement on drug prices. The planning read for 2027 is more covered lives arriving alongside closer scrutiny of Medicare Advantage, prior authorization and AI in coverage decisions. Timing runs through the January subsidy fight and the states rather than Congress, since the veto makes a federal overhaul unlikely.

💰 The Business of Care
1

CVS Health is splitting in two, unwinding a decade of vertical integration  Deals

CVS plans to separate into two publicly traded companies in a tax-free split targeted for the first half of 2028, still subject to board and regulatory approval.

CVS Health

Healthcare solutions · David Joyner

Aetna, Caremark, CVS Specialty, Oak Street Health and Signify Health. The insurance, pharmacy benefits and care delivery engine, roughly two thirds of today’s revenue.

CVS Pharmacy

Retail & community health · Prem Shah

About 9,000 pharmacies, mail pharmacy, MinuteClinic and the AI-native Health100 unit. Over $139 billion last year, about a third of revenue.

Shares fell about 13% on the news, close to $15 billion in market value, on the same day CVS beat on third quarter earnings with $2.09 adjusted EPS against a $1.65 estimate and raised its outlook. That combination is what makes the announcement worth sitting with, because investors clearly were not reacting to the quarter. The question underneath it is less about whether owning the whole continuum creates value in theory and more about whether a company that size can actually operate it, which is a version of the question every system that has built or bought its way across care delivery is going to be asked over the next two years. CVS Health

 
2

Mark Cuban tells CFOs to run every payer contract through AI  AI + Payers

At Becker’s CEO+CFO Roundtable, Cuban told hospital and employer finance chiefs to put their payer and PBM agreements through AI and ask where they are being overcharged. He pointed at thousand-page contracts that let PBMs keep rebates, redefine specialty drugs and limit audits, and used his own numbers from the Dallas Mavericks plan, the team he owns, where about $169,000 in generics would have cost roughly $19,000 at Cost Plus pricing. The price comparison is the headline, but the more useful part for a CFO is that a contract nobody has read closely since it was signed can now be read in an afternoon, which quietly changes who has the advantage in the next negotiation. The same exercise works pointed at your own managed care portfolio. Becker’s Hospital Review

 
3

UnitedHealthcare took its AI companion from 6.5M to 21M members in seven months  Payer AI

Avery answers benefits, cost, claims and provider questions inside the app and can call physician offices to book appointments, and UnitedHealthcare says it resolves about 90% of member interactions without a human, which is a figure that will draw attention given the company’s litigation over AI in coverage decisions. Resolution rate is a service measure, though, and the questions an oversight committee is likely to ask are all about the other 10%: how quickly a member reaches a person once the answer is wrong, and whether they can tell which answers came from a model in the first place. Payers are setting that standard for themselves right now, well ahead of anyone writing rules for it. Becker’s Payer

🩺 Clinical AI and Patient Health
4

Fairview picks a narrow, checkable first use case in registry abstraction  Clinical AI

Fairview Health Services has selected Layer Health to automate clinical registry abstraction, starting with the American Heart Association stroke registry and expanding into oncology and cardiology. Layer’s AI reads structured and unstructured charts and surfaces source-linked evidence for every answer, with human abstractors still in the loop, and the company reports more than 70% time savings and over 98% accuracy from earlier deployments, which are its own results rather than anything Fairview has measured yet. The choice of use case is the part worth noticing. Abstraction is bounded work that has a right answer sitting in the chart and a reviewer already attached to it, so the output can be checked instead of trusted, and that tends to be what separates the clinical AI deployments that survive contact with a health system from the ones that stall in pilot. PR Newswire

 
5

Two studies land on the same finding: accuracy scores do not predict clinical safety  AI Safety

A Doximity analysis of nine 2026 models found at least 2.3% of medication doses wrong, with 3.4% of those errors potentially lethal, and it is worth noting that Doximity also sells a checking tool. The finding holds up against the independent NOHARM benchmark from Stanford and Harvard researchers, which flagged potentially severe harm in up to roughly a quarter of benchmark consultation cases, scenarios rather than real patients, and found the harm came mostly through omissions rather than wrong statements. Read next to the Fairview item, both are pointing at the same governance problem, which is that a vendor’s accuracy score answers a different question than the one a risk committee is actually asking. Omission is also the hardest failure to catch, because nothing on the screen looks wrong.

 
6

Baylor Scott & White bets on the time between visits  Patient Health

The largest nonprofit system in Texas is working with Arianna Huffington’s Thrive Global to build ‘Microsteps,’ small science-backed nudges across food, movement, sleep, stress and connection, into its MyBSWHealth app. The premise is that outcomes are won between appointments, which is true and has also always been the part nobody gets paid for, so the thing to watch here is what they decide to measure and whether any of it ever shows up in a contract. News-Medical